锦欣生殖12月17日斥资1212.1万港元回购482.5万股
Group 1 - The company, Jinxin Reproductive Medicine (01951), announced a share buyback plan on December 17, 2025, involving an expenditure of HKD 12.121 million to repurchase 4.825 million shares [1]
Group 1 - The company, Jinxin Reproductive Medicine (01951), announced a share buyback plan on December 17, 2025, involving an expenditure of HKD 12.121 million to repurchase 4.825 million shares [1]